NIH-funded research R01 grant

Understanding how COVID-19 affects blood stem cells over time

Official title: Mechanism of the short- and long-term effects of COVID-19-induced Alarmins on hematopoietic stem and progenitor cells.

Funded at New York Blood Center · NIH-10836902 · Data updated 2026-11-12

This study is looking at how COVID-19 affects blood stem cells and the immune system over time, and it’s for people who want to help us understand how the virus changes the way our bodies produce blood cells.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionNew York Blood Center
NIH-funded
Lab location1 site (New York, United States)
Project startJuly 1, 2023
Project endJune 30, 2025
Funding year2023
Award (this year)$435,732
NIH project number7R01DK130478-03
Project IDNIH-10836902 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals who have recovered from COVID-19 and are experiencing ongoing health issues related to blood cell production.

Less likely to help

Patients who have not had COVID-19 or those without any hematological concerns may not benefit from this research.

What this research studies

This research investigates the long-term effects of COVID-19 on blood stem cells and the immune system. It focuses on how the virus alters the function and differentiation of hematopoietic stem cells (HSCs) through the release of specific proteins called alarmins. By examining the pathways involved, the study aims to uncover the mechanisms behind these changes and their implications for blood cell production. Patients may be involved in providing samples or data to help understand these effects better.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for patients suffering from long-term effects of COVID-19 on blood health.

How similar studies have gone: While the specific mechanisms of COVID-19's impact on blood stem cells are still being explored, related research has shown that viral infections can significantly affect hematopoiesis, suggesting potential for impactful findings in this area.

Where this research is happening

  • New York Blood Center
    New York, United States
    Active

Researchers

  • Principal investigator: Liang, Ying — New York Blood Center
  • Study coordinator: Liang, Ying

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.